FI814172L - Maennisko-proinsulin och daermed analoga foereningar och framstaellningsmetod genom mikrobiell polypeptid-expression och oeverfoering daerav i maennisko-insulin - Google Patents

Maennisko-proinsulin och daermed analoga foereningar och framstaellningsmetod genom mikrobiell polypeptid-expression och oeverfoering daerav i maennisko-insulin

Info

Publication number
FI814172L
FI814172L FI814172A FI814172A FI814172L FI 814172 L FI814172 L FI 814172L FI 814172 A FI814172 A FI 814172A FI 814172 A FI814172 A FI 814172A FI 814172 L FI814172 L FI 814172L
Authority
FI
Finland
Prior art keywords
och
maennisko
microbiell
framstaellningsmetod
daermed
Prior art date
Application number
FI814172A
Other languages
English (en)
Finnish (fi)
Inventor
David V Goeddel
Keiichi Itakura
Dennis G Kleid
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of FI814172L publication Critical patent/FI814172L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/61—Fusion polypeptide containing an enzyme fusion for detection (lacZ, luciferase)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Endocrinology (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
FI814172A 1981-01-02 1981-12-28 Maennisko-proinsulin och daermed analoga foereningar och framstaellningsmetod genom mikrobiell polypeptid-expression och oeverfoering daerav i maennisko-insulin FI814172L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US22204481A 1981-01-02 1981-01-02

Publications (1)

Publication Number Publication Date
FI814172L true FI814172L (fi) 1982-07-03

Family

ID=22830549

Family Applications (1)

Application Number Title Priority Date Filing Date
FI814172A FI814172L (fi) 1981-01-02 1981-12-28 Maennisko-proinsulin och daermed analoga foereningar och framstaellningsmetod genom mikrobiell polypeptid-expression och oeverfoering daerav i maennisko-insulin

Country Status (12)

Country Link
EP (1) EP0055945A3 (el)
JP (1) JPS57163352A (el)
KR (1) KR830007828A (el)
AU (1) AU7914581A (el)
DK (1) DK582481A (el)
ES (1) ES8401777A1 (el)
FI (1) FI814172L (el)
GR (1) GR78327B (el)
IL (1) IL64634A (el)
NZ (1) NZ199391A (el)
PH (1) PH20660A (el)
ZA (1) ZA818953B (el)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ199722A (en) * 1981-02-25 1985-12-13 Genentech Inc Dna transfer vector for expression of exogenous polypeptide in yeast;transformed yeast strain
CA1204682A (en) * 1981-06-19 1986-05-20 Saran A. Narang Adaptors, and synthesis and cloning of proinsulin genes
US4532207A (en) * 1982-03-19 1985-07-30 G. D. Searle & Co. Process for the preparation of polypeptides utilizing a charged amino acid polymer and exopeptidase
WO1983003413A1 (en) * 1982-03-31 1983-10-13 Genetics Inst Creation of dna sequences encoding modified proinsulin precursors
GB8308235D0 (en) * 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
IL71991A (en) * 1983-06-06 1994-05-30 Genentech Inc Preparation of human FGI and FGE in their processed form through recombinant AND tranology in prokaryotes
US4758512A (en) * 1984-03-06 1988-07-19 President And Fellows Of Harvard College Hosts and methods for producing recombinant products in high yields
DK58285D0 (da) * 1984-05-30 1985-02-08 Novo Industri As Peptider samt fremstilling og anvendelse deraf
DK129385A (da) * 1985-03-22 1986-09-23 Novo Industri As Peptider og fremstilling deraf
DK437786D0 (da) * 1986-09-12 1986-09-12 Nordisk Gentofte Insulinprecursorer
DE3716722A1 (de) * 1987-05-19 1988-12-01 Hoechst Ag Gentechnologisches verfahren zur herstellung von angiogeninen
US6875589B1 (en) 1988-06-23 2005-04-05 Hoechst Aktiengesellschaft Mini-proinsulin, its preparation and use
US5716927A (en) * 1988-12-23 1998-02-10 Novo Nordisk A/S Insulin analogs having a modified B-chain
US5514646A (en) * 1989-02-09 1996-05-07 Chance; Ronald E. Insulin analogs modified at position 29 of the B chain
AU623518B2 (en) * 1989-05-04 1992-05-14 Genentech Inc. Processes and compositions for the isolation of human relaxin
US5126249A (en) * 1989-05-09 1992-06-30 Eli Lilly And Company Enzymatic removal of a protein amino-terminal sequence
SG46612A1 (en) 1992-12-02 1998-02-20 Hoechst Ag Process for obtaining proinsulin in processing correctly linked cystine bridges
US6001604A (en) * 1993-12-29 1999-12-14 Bio-Technology General Corp. Refolding of proinsulins without addition of reducing agents
DE4405179A1 (de) * 1994-02-18 1995-08-24 Hoechst Ag Verfahren zur Gewinnung von Insulin mit korrekt verbundenen Cystinbrücken
KR0150565B1 (ko) * 1995-02-15 1998-08-17 김정재 유전자 조환에 의한 사람 인슐린 전구체의 제조 및 이를 이용한 인슐린의 제조방법
US6068993A (en) * 1997-07-02 2000-05-30 Biobras Sa Vector for expression of heterologous protein and methods for extracting recombinant protein and for purifying isolated recombinant insulin
DE19735711C2 (de) 1997-08-18 2001-04-26 Aventis Pharma Gmbh Verfahren zur Herstellung eines Vorläufers von Insulin oder Insulinderivaten mit korrekt verbundenen Cystinbrücken
KR100253916B1 (ko) * 1997-12-29 2000-05-01 김충환 사람 인슐린 전구체의 제조방법
JP4472870B2 (ja) 1998-03-31 2010-06-02 トンファ ガンテク バイオテクノロジー リミティド 分子内シャペロン様配列を含有するキメラタンパク質およびインスリン製造へのその適用
DE19838097A1 (de) 1998-08-24 2000-03-02 Hoechst Marion Roussel De Gmbh Verfahren zur chromatographischen Reinigung von Insulinen
JP3406244B2 (ja) * 1999-04-30 2003-05-12 伊藤ハム株式会社 新規な融合蛋白質からの組み換えインスリンの製造方法
US6521738B2 (en) 1999-12-29 2003-02-18 Novo Nordisk A/S Method for making insulin precursors and insulin precursor analogs
EP1246933B1 (en) * 1999-12-29 2010-07-21 Novo Nordisk A/S Method for making insulin precursors and insulin precursor analogues having improved fermentation yield in yeast
US7378390B2 (en) 1999-12-29 2008-05-27 Novo Nordisk A/S Method for making insulin precursors and insulin precursor analogues having improved fermentation yield in yeast
US6777207B2 (en) 1999-12-29 2004-08-17 Novo Nordisk A/S Method for making insulin precursors and insulin precursor analogues having improved fermentation yield in yeast
ATE328605T1 (de) 2000-03-24 2006-06-15 Genentech Inc Verwendung von insulin zur behandlung von knorpelkrankheiten
US6821755B2 (en) * 2000-07-27 2004-11-23 Boehringer Ingelheim International Gmbh Preparation of a recombinant protein in a prokaryotic host cell
AR025646A1 (es) 2000-09-13 2002-12-04 Beta Lab Sa Cepa de levaduras metilotroficas recombinantes productoras de un precursor de insulina, construcciones de adn y metodo para obtener la cepa.
KR100449454B1 (ko) * 2000-10-02 2004-09-21 이현철 단일사슬 인슐린 유도체의 유전자를 포함하는 당뇨병치료용 벡터
WO2002079251A2 (en) * 2001-04-02 2002-10-10 Novo Nordisk A/S Method for making human insulin precursors
US7105314B2 (en) 2001-04-02 2006-09-12 Novo Nordisk A/S Method for making human insulin precursors
CN100395263C (zh) 2003-01-31 2008-06-18 欧加农股份有限公司 缺氧条件下的蛋白质分离方法
AU2006272706A1 (en) 2005-07-21 2007-02-01 Abbvie Inc. Multiple gene expression including sorf constructs and methods with polyproteins, pro-proteins, and proteolysis
ES2370657T3 (es) 2005-09-14 2011-12-21 Sanofi-Aventis Deutschland Gmbh Escisión de precursores de insulinas mediante una variante de tripsina.
CA2663074A1 (en) 2006-09-22 2008-03-27 Novo Nordisk A/S Protease resistant insulin analogues
CN101173006B (zh) * 2006-10-30 2011-12-21 江苏万邦生化医药股份有限公司 一种重组人胰岛素的制备方法
US7790677B2 (en) 2006-12-13 2010-09-07 Elona Biotechnologies Insulin production methods and pro-insulin constructs
US10100098B2 (en) 2006-12-13 2018-10-16 Stelis Biopharma Private Limited Insulin production methods and proinsulin constructs
PL2201120T3 (pl) 2007-09-21 2014-05-30 Cadila Healthcare Ltd Systemy białek fuzyjnych GCSF odpowiednie do wysokiej ekspresji peptydów
CN102470165B (zh) 2009-06-26 2014-12-24 诺沃-诺迪斯克有限公司 包含胰岛素、烟酰胺和氨基酸的制剂
CA2821613A1 (en) 2010-12-14 2012-06-21 Novo Nordisk A/S Preparation comprising insulin, nicotinamide and an amino acid
CN103249427A (zh) 2010-12-14 2013-08-14 诺沃—诺迪斯克有限公司 速效胰岛素联合长效胰岛素
EP2739646B1 (en) 2011-05-10 2018-01-24 Stefan Hermann Comprehensive buffer system for renaturing human proinsulin or proinsulin derivatives
WO2013186138A1 (en) 2012-06-14 2013-12-19 Novo Nordisk A/S Preparation comprising insulin, nicotinamide and arginine
JP2016183118A (ja) * 2015-03-25 2016-10-20 東ソー株式会社 増殖因子前駆体のリフォールディング方法
EP3344651B1 (en) 2015-09-02 2022-03-02 Merck Sharp & Dohme Corp. A process for obtaining insulin with correctly formed disulfide bonds
KR20190036956A (ko) 2017-09-28 2019-04-05 한미약품 주식회사 지속형 단쇄 인슐린 아날로그 및 이의 결합체
CN112584853B (zh) 2018-09-12 2021-12-10 美药星（南京）制药有限公司 一种新型门冬胰岛素原的结构和制备门冬胰岛素的方法
AU2020418207A1 (en) 2019-12-30 2022-08-25 Gan & Lee Pharmaceuticals Co., Ltd. Long-acting GLP-1 compound
CN114901681B (zh) 2019-12-30 2024-04-09 甘李药业股份有限公司 胰岛素衍生物
WO2023143458A1 (zh) 2022-01-28 2023-08-03 甘李药业股份有限公司 酰化胰岛素

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2007676B (en) * 1977-11-08 1982-09-08 Genentech Inc Method and means for microbial polypeptide expression
US4411994A (en) * 1978-06-08 1983-10-25 The President And Fellows Of Harvard College Protein synthesis
GR71912B (el) * 1978-08-11 1983-08-16 Univ California
GR70279B (el) * 1979-09-12 1982-09-03 Univ California
DE3001928A1 (de) * 1980-01-19 1981-08-06 Hoechst Ag, 6000 Frankfurt Genprodukt eines hoeheren organismus aus einem dieses gen enthaltenden mikroorganismus
CA1200773A (en) * 1980-02-29 1986-02-18 William J. Rutter Expression linkers

Also Published As

Publication number Publication date
ES508446A0 (es) 1984-01-01
EP0055945A3 (en) 1982-09-15
DK582481A (da) 1982-08-13
IL64634A (en) 1986-03-31
ES8401777A1 (es) 1984-01-01
JPS57163352A (en) 1982-10-07
ZA818953B (en) 1983-02-23
AU7914581A (en) 1982-07-08
PH20660A (en) 1987-03-23
KR830007828A (ko) 1983-11-07
EP0055945A2 (en) 1982-07-14
NZ199391A (en) 1985-12-13
GR78327B (el) 1984-09-26
IL64634A0 (en) 1982-03-31

Similar Documents

Publication Publication Date Title
FI814172L (fi) Maennisko-proinsulin och daermed analoga foereningar och framstaellningsmetod genom mikrobiell polypeptid-expression och oeverfoering daerav i maennisko-insulin
FI822872A0 (fi) Acylfosfinoxidfoereningar och deras anvaendning
FI823486A0 (fi) Foerfarande foer bergbultning och bergbult
FI821627A0 (fi) Borrhammare avsedd foer borrning och slagborrning
FI822375A0 (fi) Bromhexin-retardformer och foerfarande foer deras framstaellning
FI821914A0 (fi) Foerfarande och belaeggningskomposition foer elektrofri doppningsbelaeggning
FI822979L (fi) Foerfarande foer foerbaettring av toleransen av roentgenkontrastmedel och genom foerfarandet erhaolkontrastmedel
FI823446A0 (fi) Foerbaettrad komposition foer maskinell diskning och skoeljning
FI821990A0 (fi) Pyrimidinderivater och foerfarande foer deras framstaellning
FI823088A0 (fi) Foerbaettringar i och angaoende tieno- och furopyridinium-substituerade kefalosporinderivat
FI822585A0 (fi) Kardiovaskulaersystem reglerande och antihypertensiva substituerade pyrrolidiner
FI822661L (fi) Foerbaettrad torkfiltvaev och torkfilt
FI822566A0 (fi) Foerfarande och anordning foer fiberlindning
FI821249L (fi) Polyamidfolier och deras framstaellningsfoerfarande
FI820215L (fi) Ihaoligt byggnadselement och byggnadselementsystem
FI813631A0 (fi) Foerstaerkt racketram och foerfarande foer framstaellning daerav
FI813206L (fi) Elektroniskt styrd frankeringsmaskin och fristaemplare
FI821547A0 (fi) Emaljeringsanordning och foerfarande foer tvao- eller flerskiktsemaljering i en braenning
FI822918A0 (fi) Transportband och framstaellningsfoerfarande
FI822341A0 (fi) Foerbaettringar i och foer benzoylfenylureaderivat
FI820380L (fi) Segmentslipsten och slipsegment
FI822042A0 (fi) Belaeggnings- och foerhydningspanel speciellt foer byggnader och dylika
FI822978A0 (fi) Jodbrombensenfoereningar och dessa innehaollande roentgenkontrastmedel
FI822833L (fi) Vingsegelfartyg och vingsegel foer detta
FI822925A0 (fi) Framstaellningsfoerfarande foer alkoxivinkaminsyraestrar och alkoxiapovinkaminsyra-estrar

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: GENENTECH, INC.